Wedbush Reiterates Outperform on argenx, Maintains $1000 Price Target

Benzinga Newsdesk www.benzinga.com Negative 69.3%

Neg 69.3% Neu 0% Pos 0%

Wedbush analyst David Nierengarten reiterates argenx (NASDAQ:ARGX) with a Outperform and maintains $1000 price target.

Comments

No comments yet. Be the first!